-
Over a 5-year period, 16% of elderly people developed mild cognitive impairment (MCI) and had double the risk of developing Alzheimer's disease (AD) than normals; however, 30% with MCI reverted to normal.
-
-
Women who do not take supplemental calcium frequently need more education, and state they would be positively influenced by their physician's recommendations.
-
Regular ingestion of caffeine, either as coffee, tea or chocolate was followed in 2 large cohorts of men and women for more than two decades. When caffeine was consumed regularly, there was no increase in the overall mortality. Indeed, a modest benefit of caffeine consumption was noted on overall mortality and in particular death related to cardiovascular disorders. This effect was more pronounced in women.
-
Women who had sexual dysfunction that was believed to be a side effect of antidepressants were more likely to report improved sexual function if they were assigned to the sildenafil, rather than to the placebo arm of a placebo-controlled trial.
-
The combination of the first direct renin inhibitor and hydrochlorothiazide was approved by the FDA this year for the treatment of hypertension.
-
After skin cancer, prostate cancer (P-CA) is the most common cancer among American men. Despite the absence of major consensus group endorsement, androgen deprivation therapy (ADT) has been sufficiently popular that in a 2003 report, ADT was employed second only to surgery for localized disease.
-
Surrogate decision makers rated communication as good but could not answer questions about resuscitation status or the care their family member was receiving.
-
As of early 2008, a minority (about 17%) of physicians have a basic or extensive electronic health record (EHR) system. Those who use electronic health records believe they improve the quality of care, and tend to be primary physicians, those practicing in large groups, hospitals, or medical centers, and those located in the western region of the United States.
-
The atrial fibrillation and congestive heart Failure (AF-CHF) trial was designed to test the hypothesis that a treatment strategy that involved rhythm control would be superior to rate control in patients with heart failure and left ventricular systolic dysfunction.
